Concepedia

Author

Anthony Sanfiz

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A Sanfiz, A. Sanfiz, Anthony Sanfiz, Anthony T. Sanfiz, Sanfiz, A.T., Sanfiz, Anthony

13

Publications

507

Citations

9

H-Index

16

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Rockefeller University
AS

About

Anthony Sanfiz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

171

2

Biochemistry

3

3

171

3

Natural Sciences

2

2

160

4

Cell Biology

1

1

149

5

Chemical Biology

1

1

11

Anthony Sanfiz

×

8

Publications

498

Citations

8

H-Index

YearCitations

Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.

Tatyana Tolkacheva, M Boddapati, Anthony Sanfiz,

PubMed

2001

149

Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence

Christoph Seibert, Martine Cadène, Anthony Sanfiz,

Proceedings of the National Academy of Sciences

2002

107

Discovery of Vibegron: A Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar,

Journal of Medicinal Chemistry

2015

101

Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder

Jerry Di Salvo, Hiroshi Nagabukuro, L. Alexandra Wickham,

Journal of Pharmacology and Experimental Therapeutics

2016

58

Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.

Sumanta Mukherjee, Leonid Zhelnin, Anthony Sanfiz,

PubMed

2019

38

Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonists for the Treatment of Overactive Bladder

Christopher R. Moyes, Richard Berger, Stephen D. Goble,

Journal of Medicinal Chemistry

2014

23

Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists

Gregori J. Morriello, Harvey R. Wendt, Alka Bansal,

Bioorganic & Medicinal Chemistry Letters

2010

11

Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes

Christoph Seibert, Anthony Sanfiz, Thomas P. Sakmar,

Methods in enzymology on CD-ROM/Methods in enzymology

2015

11

Page 1